Literature DB >> 2452202

Escape mechanisms of melanoma from immune system by soluble melanoma antigen.

K Takahashi1, K Ono, Y Hirabayashi, M Taniguchi.   

Abstract

We demonstrate in the B16 melanoma (C57BL/6 derived) system that the soluble form of tumor Ag preferentially suppresses immune responses 1) by inhibiting CTL activity in the effector phase and 2) by induction of specific Ts that block CTL generation in the induction phase. Soluble melanoma antigen Ag injected i.p. into the tumor-bearing host can effectively augment melanoma growth in vivo. Two T cell types with the L3T4+ or double-negative/I-J+ phenotype are involved in the suppression of anti-melanoma CTL responses and can easily be generated in the in vitro primary 12 h-culture. Anti-melanoma Ts recognizes the GM3(NeuAc) structure and distinguishes GM3 molecular species. This is because liposomes constructed with GM3(NeuAc) but not with GM3(NeuGc) gangliosides alone can effectively induce the melanoma-specific Ts. It is thus likely that tumor cells can escape from the immunologic surveillance system by stimulating the repertoire of Ts for self-Ag, GM3, which has existed even in the unprimed conditions in order to maintain self-tolerance. These would appear to be the major escape mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

2.  Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.

Authors:  M H Ravindranath; S M Brazeau; D L Morton
Journal:  Experientia       Date:  1994-07-15

3.  Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma.

Authors:  S Koyama; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Characteristics of T-lymphocytes infiltrating human B-cell lymphomas.

Authors:  P Marquardt; H K Müller-Hermelink
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

5.  Induction of mouse anti-melanoma cytotoxic and suppressor T cells in vitro by an artificial antigen, GM3-lactone.

Authors:  Y Harada; M Sakatsume; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1990-04

6.  Density of GM3 with normal primary structure determines mouse melanoma antigenicity; a new concept of tumor antigen.

Authors:  Y Harada; M Sakatsume; G A Nores; S Hakomori; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1989-10

7.  Properties of mouse melanoma antigen and its secretion mechanism from the cell surface.

Authors:  I Kuwabara; M Tagawa; Y Harada; T Ito; M Taniguchi
Journal:  Jpn J Cancer Res       Date:  1989-10

8.  GD2 oligosaccharide: target for cytotoxic T lymphocytes.

Authors:  X J Zhao; N K Cheung
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Isolation of genomic DNA controlling mouse melanoma antigen defined by monoclonal antibody.

Authors:  A Okitsu; M Tagawa; Y Tamura; M Kanno; H Matsubara; T Ito; K Imai; K Shigemoto; I Nakamura; H Koseki
Journal:  Jpn J Cancer Res       Date:  1988-06

10.  Immunosuppressive effect of shedding intercellular adhesion molecule 1 antigen on cell-mediated cytotoxicity against tumor cells.

Authors:  S Koyama
Journal:  Jpn J Cancer Res       Date:  1994-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.